ENTOURAGE

Welcome to the Brand page for “ENTOURAGE”, which is offered here for Pharmaceutical research and development for medicines including cannabinoids and/or cannabidiol (cbd), with a delta-9 tetrahydrocannabinol (thc) concentration of not more than 0.3 percent on a dry weight basis, for the treatment of refractory epilepsy, epilepsy, autism and anxiety; scientific and medical research in the field of cannabinoids and/or cannabidiol (cbd) contained medicines, with a delta-9 tetrahydrocannabinol (thc) concentration of not more than 0.3 percent on a dry weight basis, for the treatment of refractory epilepsy, epilepsy, autism and anxiety;.

Its status is currently believed to be active. Its class is unavailable. “ENTOURAGE” is believed to be currently owned by “ENTOURAGE PARTICIPAÇÕES S.A.”